PremiumThe FlyBiora Therapeutics reports Q3 EPS ($5.04) vs (35c) last year BIOR Earnings Report this Week: Is It a Buy, Ahead of Earnings? Biora to sell 745,342 shares at $4.025 in registered direct offering PremiumThe FlyBiora Therapeutics granted extension to regain compliance with Nasdaq Biora Therapeutics reports Q2 EPS (4c), consensus (45c) Biora Therapeutics Restructures Debt and Issues New Securities PremiumThe FlyBiora Therapeutics announces clinical trial results for BT-600 Biora Therapeutics files to sell 2.23M shares of common stock for holders Biora Therapeutics files $200M mixed securities shelf